Hypericum perforatum extract
CAS 84082-80-4
Hypericum perforatum extract (CAS 84082-80-4) is a pharmaceutical compound with 0 bioactivity targets and 57 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Hypericum perforatum extract is linked through DSSTox identifiers.
View industrial chemical data →Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Hypericum perforatum extract used for in pharmaceutical contexts?
Hypericum perforatum extract (CAS 84082-80-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Hypericum perforatum extract?
Hypericum perforatum extract has 57 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Acne, Anion gap increased, Anxiety, Back pain, Blood glucose increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Hypericum perforatum extract also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Hypericum Perforatum Extract with EU status "restricted".
What clinical phase is Hypericum perforatum extract in?
No phase 1-4 clinical development badge is rendered for Hypericum perforatum extract because the matched compound identifier rows do not contain a max-phase value.